Geometric mean concentration-time profiles of (A) racemic BUP, R-BUP, and S-BUP; (B) racemic OHBUP, RR-OHBUP, and SS-OHBUP; (C) racemic ERY, SR-ERYHBUP,

Slides:



Advertisements
Similar presentations
Plasma leucine (A), phenylalanine (B) and threonine (C) concentrations following ingestion of either 20 or 40 g of whey protein isolate in both the lower.
Advertisements

Rate of phenylalanine oxidation (A) and plasma urea concentrations (B) following ingestion of either 20 or 40 g of whey protein isolate in both the lower.
Representative 10-s EEG recordings from GAERS: during baseline (prior to injection of any drug) (i), following the i.c.v. injection of 4 μl of vehicle.
Parallels in antimicrobial peptide mechanisms of action and resistance
Requirement for a β subunit for the modulation of whole-cell CaV2
COX-1 and known variants.
Prevalence of atopic sensitization and asthma in children aged 13 years with a history of thumb-sucking or nail-biting. Prevalence of atopic sensitization.
Comparison of the model incorporating daily dose to that incorporating Cmax. Comparison of the model incorporating daily dose to that incorporating Cmax.
Evaluation of models incorporating the base covariates.
Kenneth Todd Moore, MS, Dino Kröll, MD 
The context-sensitive half-times for commonly used intravenous anesthetic drugs. [Reproduced from Reves JG, Glass PSA, Lubarsky DA, McEvoy MD, and Martinez-Ruiz.
Representative radio-HPLC chromatograms for individual pooled methanolic fecal extracts for periods of maximum recovery of radioactivity after dosing of.
Mean (± S.E.) change from baseline in the 6-min walk distance for bosentan (n = 21) and placebo (n = 11) groups. Mean (± S.E.) change from baseline in.
Zachary M. Sellers, Lori McGlocklin, Andrea Brasch 
Total ion current-EMS chromatograms of SB939 and its metabolites after incubation in liver microsomal fractions for 60 min at a concentration of 50 μM.
Structure of solid lipid nanoparticles (SLNs).
The three primary ADC components that determine which cells are targeted (antibody), how the drug is released (linker/trigger), and the mechanism of action.
Adjusted rate ratios of hospital days and admissions for blacks and Hispanics compared with whites by age group. Adjusted rate ratios of hospital days.
Mechanisms of H2S release from S-aroylthiooximes (SATOs).
James F. List, Jean M. Whaley  Kidney International 
Model B. The melatonin-produced increase in extracellular dopamine concentration in the striatum is prevented by the CYP2D inhibitor propafenone in pargyline-pretreated.
Cytotoxic activities of polymer micelles containing CFZ in H460 (A) and select micelle formulations in RPMI-8226 (B) cell lines. Cytotoxic activities of.
Cytotoxic effects of PM1 and PM2 empty particle controls and coincubation of CFZ with empty particles tested in H460 (A) and RPMI-8226 (B) cells. Cytotoxic.
The additive model assumes unspecific effects of equal size in both the placebo and drug arm or groups of studies or experiments. The additive model assumes.
Plasma concentration–time profile, relative bioavailability and pharmacokinetic (PK) parameters of 4 mg TAK-228 in the single-agent QD PK run-in period,
Observed (symbols) and model predicted (lines) dopamine time courses in rats following D-amphetamine administration. Observed (symbols) and model predicted.
Concentrations of abemaciclib in plasma and cerebrospinal fluid (CSF).
Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin  G. Drusano  Clinical Microbiology and Infection 
Blood alcohol concentration and psychomotor effects
Comparison of the observed and calculated CLR values of taurine and GCDCA-S. Comparison of the observed and calculated CLR values of taurine and GCDCA-S.
Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?
Chronic effect of 28-day oral administration of vehicle (n = 6–10/group) or aprocitentan 1, 10, and 100 mg/kg per day (n = 6–9/group) on mean arterial.
Effect of 11-day oral administration of vehicle (n = 4) or 6-day oral administration of enalapril 10 mg/kg per day (n = 19), followed by 5-day oral administration.
Coalescent analysis of nucleotide differentiation between high and low latitude samples. Coalescent analysis of nucleotide differentiation between high.
Effects of gemfibrozil on the exposure (area under the plasma drug concentration-time curve) to different CYP2C8 substrate drugs. Effects of gemfibrozil.
(A) Plasma renin activity in Wistar rats, SHRs, and DOCA-salt rats, n = 8 to 9/group; data are presented as mean ± S.E.M. Dose-response relationship on.
Schematic illustration of the interaction between CYP2C8 and its glucuronide substrates. Schematic illustration of the interaction between CYP2C8 and its.
Results of thermogravimetric measurements of peptide ghrelin antagonist (GhA) and loaded into PSi microparticles. Results of thermogravimetric measurements.
Drug levels during the course of a dosing interval.
A: PPG increment at week 26 for mealtime faster aspart versus IAsp.
Observed (symbols) and predicted (solid lines, eq
Typical response-time courses obtained after different doses and routes of administration (3 and 10 µg i.v., and 10, 50, and 100 µg s.c.). Typical response-time.
Concentration-time profiles of repeated weekly infusions of (A) 720 mg and (B) 990 mg tomuzotuximab measured in individual patients before and at the end.
Chen Cheng1 et al. Acta Pharmacol Sin 2013; 34: 1337–1348;
Dose-normalized plasma concentration-time curves of a mAb following subcutaneous (SC) and intravenous (IV) administration to cynomolgus monkeys (mean ±
Half-life of removal from subcutaneous administration site after subcutaneous administration of fluorescence-labeled VEGF-C156S, ovalbumin (OVA), bovine.
Fraction of dose (mean, n = 3–4) recovered in peripheral lymph following subcutaneous administration to sheep for a series of small molecular compounds.
Stereoimage of three independent docking simulations of the interaction between clopidogrel acyl 1-β-d-glucuronide and the active site of CYP2C8. Stereoimage.
A loading dose decreases the time to achieve the target concentration.
Damage-associated molecular pattern (DAMP)-induced activation of Toll-like receptors (TLRs). Damage-associated molecular pattern (DAMP)-induced activation.
CBD elevates AEA levels in poly-(I:C)–stimulated HaCaT cells after 6 hours. CBD elevates AEA levels in poly-(I:C)–stimulated HaCaT cells after 6 hours.
CBD and other phytocannabinoids are not cytotoxic in HaCaT cells.
The CYP2C8 gene is located to the CYP2C gene cluster on chromosome 10.
Diagnostic plots of the TGI PKPD model fitted to the A677 TGI data.
Schematic illustration of MRP4 regulation pathway.
Unbound drug concentrations in plasma (dotted) and brain ISF (solid, calculated from recovery and dialysate concentration) following repeated subcutaneous.
AEA and URB597 reduce MCP-2, IL-6, and IL-8 levels in poly-(I:C)–stimulated HaCaT cells after 6 hours. AEA and URB597 reduce MCP-2, IL-6, and IL-8 levels.
Involvement of cys298 in the interaction of PGA1 with AKR1B1.
Activation and desensitization of the α7 nAChRs.
The effect of a change in the expression level of the receptor and the binding affinity on the subcutaneous bioavailability of mAbs. The effect of a change.
Colony formation of K-562 cells after 24 h (upper panel) or 48 h (lower panel) exposure to ErPC3 (20 μm) and ASO-bcr (10 μm), respectively. Colony formation.
95% Confidence Interval for Mean
The odds ratio comparing phonation to the breath-hold technique is given above the glottis, at the glottis, and below the glottis. The odds ratio comparing.
Neighbor joining tree showing relationships between the human cannabinoid CB1 and CB2 receptors and other human rhodopsin α-group type G protein-coupled.
Average trastuzumab serum concentrations in female minipigs following single subcutaneous administration of trastuzumab in formulations without and with.
Discrimination accuracy across conditions.
Allometric relationship between the lymph flow in the thoracic duct and species body weight. Allometric relationship between the lymph flow in the thoracic.
Dose adjustments in patients with CKD are based on the change in the concentration-time profile for the drug of interest. Dose adjustments in patients.
Plasma concentration-time profile after oral administration of a single dose. Plasma concentration-time profile after oral administration of a single dose.
(Left) Observed (symbols) and predicted (lines) response (bacterial count, CFU) vs. time after administration of 1.5, 2, 4, and 6 µg of a new antibiotic.
Presentation transcript:

Geometric mean concentration-time profiles of (A) racemic BUP, R-BUP, and S-BUP; (B) racemic OHBUP, RR-OHBUP, and SS-OHBUP; (C) racemic ERY, SR-ERYHBUP, and RS-ERYHBUP; and (D) THR, RR-THRHBUP, and SS-THRHBUP in 15 healthy volunteers after a single 100-mg oral dose of racemic BUP. Symbols and error bars denote observed geometric means and limits of the 95% confidence interval, respectively. Geometric mean concentration-time profiles of (A) racemic BUP, R-BUP, and S-BUP; (B) racemic OHBUP, RR-OHBUP, and SS-OHBUP; (C) racemic ERY, SR-ERYHBUP, and RS-ERYHBUP; and (D) THR, RR-THRHBUP, and SS-THRHBUP in 15 healthy volunteers after a single 100-mg oral dose of racemic BUP. Symbols and error bars denote observed geometric means and limits of the 95% confidence interval, respectively. Andrea R. Masters et al. J Pharmacol Exp Ther 2016;358:230-238 Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics